BALYASNY ASSET MANAGEMENT L.P. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 114 filers reported holding IMMUNOVANT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$13,436,500
+177.0%
350,000
+36.9%
0.03%
+145.5%
Q2 2023$4,850,193
-27.3%
255,677
-32.0%
0.01%
-38.9%
Q4 2022$6,670,006
+678.3%
375,775
+144.8%
0.02%
+500.0%
Q3 2022$857,000
+958.0%
153,503
+950.2%
0.00%
Q1 2022$81,000
-97.1%
14,616
-75.6%
0.00%
-100.0%
Q4 2020$2,770,00059,9740.02%
Other shareholders
IMMUNOVANT INC shareholders Q3 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 1,439,544$27,308,1508.29%
Logos Global Management LP 2,250,000$42,682,5005.80%
Deep Track Capital, LP 5,421,330$102,842,6304.76%
TCG Crossover Management, LLC 654,853$12,422,5612.04%
COMMODORE CAPITAL LP 900,000$17,073,0001.92%
ACUTA CAPITAL PARTNERS, LLC 141,755$2,689,0921.82%
Affinity Asset Advisors, LLC 260,000$4,932,2001.72%
HighVista Strategies LLC 180,320$3,420,6701.56%
Redmile Group, LLC 1,921,152$36,444,2531.40%
Perceptive Advisors 2,523,783$47,876,1641.39%
View complete list of IMMUNOVANT INC shareholders